TeraWulf Inc (WULF) Stock Price Today
Sempra rings NYSE bell, announces $65B capital plan to expand U.S. utility infrastructure.
Sempra celebrated its growth by ringing the opening bell at the NYSE, highlighting its $65 billion capital plan focused on expanding and modernizing energy infrastructure in major U.S. markets, especially California and Texas. The company aims to gen...
Filament Health ships psilocybin drug PEX010 to Australia for first trial combining psychedelics with physiotherapy in movement disorders.
Filament Health has shipped its patented psilocybin drug candidate PEX010 to Austin Health in Melbourne for the PSI-PHY trial, the first study to combine psilocybin-assisted physiotherapy for refractory motor functional neurological disorder (FND). S...
Affirm sees strong Q4 growth driven by BNPL and Affirm Card, despite macroeconomic challenges.
Affirm reported strong double-digit growth in gross merchandise volume and active users in Q4, fueled by increased adoption of its Buy Now Pay Later (BNPL) services and rapid uptake of the Affirm Card, which now accounts for 20% of total GMV. Despite...
JEPI ETF offers steady income but caps upside; KO, JNJ, PG stocks provide dividend growth and uncapped gains.
The JPMorgan Equity Premium Income ETF (JEPI) delivers attractive monthly income by selling call options, which caps its upside potential. In contrast, three Dividend Kings—Coca-Cola, Johnson & Johnson, and Procter & Gamble—offer lower initial yields...
AI will find a cancer cure within our lifetime, says Arm CEO Rene Haas.
Rene Haas, CEO of chip designer Arm Holdings, predicts that AI will eventually find a cure for cancer within our lifetime by solving complex DNA modeling problems. He highlighted that current AI and human capabilities are insufficient but expect adva...
AstraZeneca's new COPD drug shows strong trial results, aiming for $5B annual sales by 2030.
AstraZeneca released full data from two late-stage trials of its experimental COPD drug, tozorakimab, showing significant reduction in flare-ups among both former and current smokers. The drug, under FDA priority review with expected approval in earl...
TuHURA CEO to present at H.C. Wainwright conference on cancer immunotherapy progress
TuHURA Biosciences announced that CEO James A. Bianco will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14. The company is focused on developing novel immuno-oncology therapies to overcome resistance to cancer ...
Breaking up Netflix is complex due to its integrated business model and shared global assets.
Netflix's $326 billion streaming business is deeply integrated, making a breakup difficult. Its financials do not separate profits by segments like ads, games, or live events, and global content and technology costs are shared. Splitting the studio f...
Marvell stock reverses gains after Nvidia CEO's bullish call, with AI models predicting mixed outlook.
Marvell's stock erased most gains following Nvidia CEO Jensen Huang's positive remarks about the company. Finbold's AI analysis predicts a mixed outlook for Marvell, with price targets ranging from a 7.74% drop to a 5.48% rise by September 30, 2026. ...
Oracle challenges AWS with aggressive pricing and strong AI cloud contracts, but AWS leads in cash flow and scale.
Oracle is aggressively undercutting AWS on cloud infrastructure pricing and securing large AI-related contracts, with its cloud revenue up 93% year-over-year and a massive backlog of $638 billion. Meanwhile, AWS posted strong growth with $42.23 billi...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.